[show abstract][hide abstract] ABSTRACT: Objective: The aim of this study was to evaluate the short-term clinical performance of the Pericarbon Freedom stentless bioprosthesis (Sorin Solo). Methods and Results: Between 2006 and 2007, a total of 45 consecutive patients at our institution (33 male,73% , mean age 62±12 years) underwent aortic valve replacement with Pericarbon Freedom stentless bioprothesis with a single suture line. 38 patients underwent aortic valve replacement for aortic stenosis (group 1) and 7 patients for aortic regurgitation (group 2). Echocardiograpic parameters for each group were compared. On the third month, no paravalvuler leak or no transvalvular regurgitation more than trivial was detected with echocardiographic examination. Left ventricular end diastolic diameter significantly reduced in group 2 (p<0.05). Interventricular septum and posterior wall thickness significantly reduced in group 1 (p<0.05). There was no complication attributed to the valve itself. Conclusion: Supra-annular implantation technique with the Pericarbon Freedom stentless bioprosthesis (Sorin Solo), a latest generation pericardial stentless valve are assosiated witha an excellent short-term results in terms of safety and hemodynamics.
The Anatolian Journal of Clinical Investigation. 01/2008;